Form 4: Lemaitre Vascular Director Reports Accrual of Dividend Equivalent Rights

Bridget A. Ross, a Director at Lemaitre Vascular Inc., has reported the acquisition of dividend equivalent rights tied to her existing equity awards, as detailed in a recent SEC Form 4 filing.

Summary

• Bridget A. Ross, a Director of Lemaitre Vascular Inc. (LMAT), filed a Form 4 reporting changes in her beneficial ownership.
• The filing indicates the acquisition of Dividend Equivalent Rights (DERs) on May 29, 2025.
• These DERs are economic equivalents of one share of the Issuer's common stock and accrue on previously granted restricted stock unit (RSU) and Performance Share Unit (PSU) awards.
• The DERs vest proportionately with their respective underlying RSU and PSU awards.
• Specific accruals include 0.4985 DERs on an RSU award from December 12, 2022, 0.4985 DERs on a PSU award from December 12, 2022, 0.8524 DERs on an RSU award from December 8, 2023, 1.0208 DERs on a PSU award from December 8, 2023, and 1.0387 DERs on an RSU award from December 6, 2024.
• The reported price for these acquisitions was $0, as they represent accrued rights, not direct stock purchases.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's a routine compensation event, the accrual of dividend equivalent rights indicates continued alignment of the director's interests with shareholders and no negative insider selling activity.

Positives

• The accrual of Dividend Equivalent Rights indicates the director's continued participation in the company's equity incentive plans, aligning their interests with those of shareholders.
• This transaction is a routine part of executive compensation and does not represent a sale of company stock by an insider.

Future Outlook

The Dividend Equivalent Rights will vest proportionately with their underlying Restricted Stock Unit and Performance Share Unit awards, indicating future potential share entitlements for the director.

Industry Context

This filing is a routine disclosure of insider compensation and does not provide broader industry context or trends. It reflects standard practices for equity-based compensation for directors in publicly traded companies.

Stakeholder Impact

• Shareholders: The accrual of dividend equivalent rights aligns the director's financial interests with those of common shareholders, as these rights are tied to the company's common stock and vest with performance/time-based awards.

Next Steps

• Continued vesting of the underlying Restricted Stock Unit (RSU) and Performance Share Unit (PSU) awards, along with the associated Dividend Equivalent Rights.

Key Dates

Keywords

Lemaitre Vascular, LMAT, SEC Form 4, Insider Transaction, Beneficial Ownership, Dividend Equivalent Rights, Restricted Stock Units, Performance Share Units, Director Compensation